<?xml version="1.0" encoding="UTF-8"?>
<p id="Par87">The proportions of patients with cognitive deterioration, QoL deterioration and functional independence deterioration will be compared between treatment arms using Fisher's exact test. A sensitivity analysis will be conducted assuming patients who had not completed the neurocognitive assessment or had passed away prior to the assessment time-point, had cognitive deterioration. Change from baseline values will be compared using 2-sample t-tests and repeated measures linear regression, adjusting for the stratification variable (number of brain metastases).</p>
